FDA: Risk Tied to Some Antiviral Medications
The US Food and Drug Administration (FDA) has issued a warning about the potential for hepatitis B virus (HBV) reactivation with the use of certain antivirals.
A Four-in-One Hit to Hep C
The US Food and Drug Administration has approved a tablet that contains four medications in one tablet to treat hepatitis C.
First and Only Dronabinol Solution Approved
The US Food and Drug Administration has approved the first and only dronabinol solution for oral use.
New Hepatitis C Rx Approved
The US Food and Drug Administration (FDA) has approved a new hepatitis C medication.
HIV Has a New Treatment
The US Food and Drug Administration (FDA) has approved Descovy (emtricitabine, tenofovir alafenamide) to treat human immunodeficiency virus (HIV).
This Rx Might Help Prevent HIV
An ounce of prevention is a good thing when it comes to HIV infection.
Smallest Single-Tablet HIV Rx Approved
Sometimes treatments for big diseases come in small packages.
Why Safe Sex Could Protect You From Zika
Zika is primarily spread by mosquitoes. But that may not be the only way to contract the virus.
FDA Expands Label for Daklinza
On February 5, 2016, FDA approved changes to the DAKLINZA(daclatasvir) label to expand the indication to include HCV genotype 1 infection and expand dosage recommendations to the following populations and to revise dosage recommendations for HCV genotype 3 subjects with compensated (Child-Pugh A) cirrhosis:
FDA OKs New Hep C Rx
The U.S. Food and Drug Administration today approved Zepatier (elbasvir and grazoprevir) with or without ribavirin for the treatment of chronic hepatitis C virus (HCV) genotypes 1 and 4 infections in adult patients.